Sanofi (SNY) Non-Current Receivables (2018 - 2025)
Historic Non-Current Receivables for Sanofi (SNY) over the last 8 years, with Q4 2025 value amounting to $640.3 million.
- Sanofi's Non-Current Receivables rose 699.66% to $640.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $640.3 million, marking a year-over-year increase of 699.66%. This contributed to the annual value of $621.6 million for FY2025, which is 254.85% up from last year.
- Sanofi's Non-Current Receivables amounted to $640.3 million in Q4 2025, which was up 699.66% from $1.9 billion recorded in Q3 2025.
- In the past 5 years, Sanofi's Non-Current Receivables registered a high of $1.9 billion during Q3 2025, and its lowest value of $138.9 million during Q2 2024.
- In the last 5 years, Sanofi's Non-Current Receivables had a median value of $254.1 million in 2022 and averaged $569.6 million.
- In the last 5 years, Sanofi's Non-Current Receivables plummeted by 4684.41% in 2024 and then skyrocketed by 34082.69% in 2025.
- Sanofi's Non-Current Receivables (Quarter) stood at $200.2 million in 2021, then grew by 23.33% to $246.9 million in 2022, then decreased by 18.07% to $202.3 million in 2023, then surged by 195.84% to $598.4 million in 2024, then rose by 7.0% to $640.3 million in 2025.
- Its Non-Current Receivables stands at $640.3 million for Q4 2025, versus $1.9 billion for Q3 2025 and $612.4 million for Q2 2025.